In This Issue:

Focus On IP and Life Sciences:

Intellectual Property Planning and the Creation of Value By Rohan Massey and Peter Nias 4; Court Ruling Strikes Down Gene Patents on Appeal By William (Bill) Gaede 6; SPCs: Is a Simplistic System Becoming Too Complicated? By Hiroshi Sheraton and Robert Lundie Smith 8; Controlling and Processing Data in EU Clinical Trials By Rohan Massey and Paul Melot de Beauregard 10; and, An End to Free Pricing in the German Pharmaceuticals Market By Stephan Rau 12.

Features:

“Public Policy” and the Enforcement of Foreign Arbitration Awards in China By Henry Chen and B. Ted Howes 14; Initial Guidance on the US Foreign Account Tax Compliance Act By Andrew Stone and David Adler 16; New Massachusetts Law: The Start of a US Trend toward EU Privacy Principles in the Workplace? By Heather Egan Sussman and Alison Wetherfield 18; Dodd-Frank Act Effect on Non-US Investment Advisers By Edwin (Ted) Laurenson 20; Online Gambling Opened Up to Competition in France: Implications of Expected Reform By Patrice Corbiau and Mélanie Bruneau 21; And, Avoiding Those “Oh Sh!#” Moments By Eileen O’Connor 22.